Viewing Study NCT02260050


Ignite Creation Date: 2025-12-24 @ 5:24 PM
Ignite Modification Date: 2026-04-13 @ 12:50 AM
Study NCT ID: NCT02260050
Status: COMPLETED
Last Update Posted: 2014-10-09
First Post: 2014-10-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bioequivalence of the New Formulation of WAL 801 CL Dry Syrup Compared to the Conventional Formulation of WAL 801 CL Dry Syrup in Healthy Male Volunteers
Sponsor: Boehringer Ingelheim
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module